Market Place
Sourcing Support
Lilly, Biogen, Eisai, Genentech Sponsor `Let`s Talk Alzheimer`s`
12 Jun 2026 //
FIERCE PHARMA
Eli Lilly Invests in Startup Abridge for Trial Recruitment
12 Jun 2026 //
ENDPOINTS
ADA: Novo`s Lange Says Jury`s Out on CagriSema vs Retatrutide
10 Jun 2026 //
FIERCE BIOTECH
Eli Lilly Canada Gets Québec Reimbursement of Verzenio for MBC
10 Jun 2026 //
FIRSTWORD PHARMA
Eli Lilly Calls for Authentic Patient Portrayals at Tribeca
10 Jun 2026 //
FIERCE PHARMA
Lilly Claims Data Deadline May Spark New 340B Dispute
09 Jun 2026 //
ENDPOINTS
Lilly Deepens Alzheimer`s Research with AlzeCure License
09 Jun 2026 //
FIERCE BIOTECH
Lilly`s Oral GLP-1 Foundayo Excels in Three Phase 3 Trials
08 Jun 2026 //
PR NEWSWIRE
ADA: Lilly Sets Weight Loss Record with Next-Gen Asset
08 Jun 2026 //
BIOSPACE
Lilly`s Weight Loss Drug Shows Benefits in Menopause, Sleep Apnea
07 Jun 2026 //
PR NEWSWIRE
Lilly`s Foundayo Drives Weight Loss Across Menopause Stages
07 Jun 2026 //
PR NEWSWIRE
Lilly`s Triple-G Shows Impressive Efficacy in Obesity & Diabetes
06 Jun 2026 //
FIERCE BIOTECH
Lilly and Novo Clash at ADA 2026 as Rivals Chase Obesity Market
05 Jun 2026 //
BIOSPACE
FICCI Launches Bharat Life Sciences Awards with Eli Lilly India
04 Jun 2026 //
EXPRESSPHARMA
Weight Watchers to Expand Weight Loss Access via LillyDirect
04 Jun 2026 //
GLOBENEWSWIRE
Lilly gains license for Ascidian`s Gene-Editing Tech
03 Jun 2026 //
PRESS RELEASE
Lilly to halve planned €2.3 Billion Investment in Germany
03 Jun 2026 //
REUTERS
Eli Lilly`s Ultimatum to Hospitals: Send 340B claims data
03 Jun 2026 //
FIERCE PHARMA
Lilly to Highlight Hematology Portfolio at EHA 2026
02 Jun 2026 //
PR NEWSWIRE
Camurus Announces Expansion Of Lilly Collaboration
01 Jun 2026 //
PR NEWSWIRE
Obesity Davids And Goliaths Face Off At ADA 2026
01 Jun 2026 //
BIOSPACE
Haisco And Lilly Partner To Develop Innovative Medicines Across
01 Jun 2026 //
PR NEWSWIRE
Lilly`s Verzenio Set as New Standard in Recurrent Liposarcoma
31 May 2026 //
FIRSTWORD PHARMA
Lilly`s Retevmo Cuts Recurrence Risk 83% in RET Lung Cancer
31 May 2026 //
PR NEWSWIRE
Hanmi Signs Licensing Deal with Lilly for sonefpeglutide
31 May 2026 //
PR NEWSWIRE
Post-Hoc: Lilly Gets More Secretive And Hides Phase 1 Pipeline
29 May 2026 //
ENDPOINTS
CVS Restores Zepbound Coverage, Adds New Pill Foundayo
28 May 2026 //
FIERCE PHARMA
Lilly to Present Foundayo, Mounjaro Data at ADA 2026
28 May 2026 //
PR NEWSWIRE
Lilly Participates in Goldman Sachs Annual Healthcare Conference
27 May 2026 //
PR NEWSWIRE
Eli Lilly Wins Argument Over Noom`s GLP-1 Dosing Claims
27 May 2026 //
FIERCE PHARMA
Lilly Announces 3 Acquisitions to Build Infectious Disease Portfo
26 May 2026 //
PRESS RELEASE
Lilly`s VERVE-102 Cuts PCSK9 by 88% & LDL-C by 62% in Single Dose
25 May 2026 //
PR NEWSWIRE
Oral GLP-1 Race Heats Up As Lilly`s Foundayo Shines In Seniors
25 May 2026 //
INDPHARMAPOST
Lilly To Present Oncology Portfolio At ASCO Meeting 2026
22 May 2026 //
PR NEWSWIRE
Eli Lilly Names Chandan S. Senior Director of Data Science and AI
22 May 2026 //
INDPHARMAPOST
Lilly, BMS, Incyte Strike Deals to Keep AI Momentum Rolling
22 May 2026 //
BIOSPACE
Lilly Says Next-Gen Obesity Drug Helps Patients Lose 28% Weight
22 May 2026 //
REUTERS
Lilly Accuses Church Pharmacies of $200M Rebate Fraud
21 May 2026 //
FIERCE PHARMA
CDD Partners with Lilly TuneLab to Share AI/ML Models
20 May 2026 //
PR NEWSWIRE
Eli Lilly FCA Judgment Finalized at $220M+ After SCOTUS Denial
19 May 2026 //
PR NEWSWIRE
Two Pharma Firms Own Nearly 100% of GLP-1 Citations in AI
19 May 2026 //
PR NEWSWIRE
US Supreme Court Rejects Eli Lilly`s Whistleblower Law Challenge
18 May 2026 //
REUTERS
Lilly to Participate in Bernstein`s 42nd Annual Conference
18 May 2026 //
PR NEWSWIRE
4 Startups Named Most Innovative Life Sciences at Biomed Israel
15 May 2026 //
PR NEWSWIRE
Eli Lilly Introduces Lormalzi For Early Alzheimer`s Treatment
15 May 2026 //
INDPHARMAPOST
Lilly and UNICEF Collaborate to Improve Children`s Health
14 May 2026 //
PR NEWSWIRE
The Rise of GPCRs, Radiopharma & Peptide Screening
14 May 2026 //
BIOSPACE
Lilly Sustains Weight Loss Lead With Foundayo, Zepbound
13 May 2026 //
BIOSPACE
Low Weight Regain Seen After Switch to Obesity Pill
13 May 2026 //
REUTERS
Eli Lilly Pledges 500K Meals and Cold Storage for 150 Pantries
12 May 2026 //
PR NEWSWIRE
Lilly Eyes Low-Dose Zepbound, Foundayo for Weight Loss
12 May 2026 //
ENDPOINTS
Eli Lilly Halts India Obesity Campaign Amid Regulatory Scrutiny
12 May 2026 //
ECONOMICTIMES
Lilly`s Foundayo & Low-Dose Zepbound Help Maintain Weight Loss
12 May 2026 //
PR NEWSWIRE
Omada Health Joins Lilly Employer Connect for GLP-1 Care
07 May 2026 //
GLOBENEWSWIRE
Novo and Lilly Gain on Weight-Loss Pill Market Signals
07 May 2026 //
REUTERS
Lilly Pledges $4.5 Billion More To Indiana Manufacturing Campus
06 May 2026 //
PR NEWSWIRE
Lilly`s Omvoh Show 4-Year Durable Clearance in Ulcerative Colitis
05 May 2026 //
PR NEWSWIRE
Foundayo`s Liver Failure Blip Impacts Lilly Shares, Analysts
05 May 2026 //
BIOSPACE
Lilly Declares Second-Quarter 2026 Dividend
04 May 2026 //
PR NEWSWIRE
Lilly`s Obesity Pill Hits 6,000 Prescriptions in Third Month
01 May 2026 //
REUTERS
